Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study
- PMID: 34626489
- PMCID: PMC10835603
- DOI: 10.1111/apt.16630
Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study
Abstract
Background: Rumination syndrome is a functional gastroduodenal disorder characterised by effortless regurgitation of recently ingested food. Emerging evidence reports duodenal eosinophilic inflammation in a subset, suggesting a shared pathophysiology with functional dyspepsia (FD).
Aim: To assess the clinical features of rumination syndrome and FD in a community-based study.
Methods: We mailed a survey assessing gastrointestinal symptoms, diet and psychological symptoms to 9835 residents of Olmsted County, MN, USA in 2017-2018; diagnostic codes were obtained from linked clinical records. The two disorders were assessed as mutually exclusive in 'pure' forms with a separate overlap group, all compared to a control group not meeting criteria for either. Prevalence of associations, and univariate and independent associations with predictors were assessed by logistic regression.
Results: Prevalence of rumination syndrome and FD were 5.8% and 7.1%, respectively; the overlap was 3.83-times more likely than expected by chance. Independent predictors for rumination (odds ratio (OR), 95% confidence interval (CI)) were female gender (1.79, 1.21-2.63), smoking (1.89, 1.28-2.78), gluten-free diet (1.58, 1.14-2.19), allergic rhinitis (1.45, 1.01-2.08) and depression (1.10, 1.05-1.16). FD was independently associated with female gender, depression, non-coeliac wheat sensitivity, migraine, irritable bowel syndrome and somatic symptoms. A similar reported efficacy (≥54%) of low fat or dairy-free diets was found with both disorders (P = 0.53 and P = 1.00, respectively). The strongest independent associations with overlapping FD and rumination syndrome were a history of rheumatoid arthritis (3.93, 1.28-12.06) and asthma (3.02, 1.44-6.34).
Conclusion: Rumination syndrome overlaps with FD with a shared risk factor profile, suggesting a common pathophysiology.
© 2021 John Wiley & Sons Ltd.
Figures








Comment in
-
Editorial: rumination-more frequent than previously thought. Authors' reply.Aliment Pharmacol Ther. 2022 Jan;55(1):114-115. doi: 10.1111/apt.16682. Aliment Pharmacol Ther. 2022. PMID: 34907562 No abstract available.
-
Editorial: rumination-more frequent than previously thought.Aliment Pharmacol Ther. 2022 Jan;55(1):112-113. doi: 10.1111/apt.16660. Aliment Pharmacol Ther. 2022. PMID: 34907563 No abstract available.
-
Letter: eosinophilic duodenitis and increased intraepithelial lymphocytes in rumination syndrome - more evidence.Aliment Pharmacol Ther. 2023 Jun;57(11):1353-1354. doi: 10.1111/apt.17481. Aliment Pharmacol Ther. 2023. PMID: 37161636 No abstract available.
References
-
- Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal disorders. Gastroenterology. 2016;150(6):1380–92. - PubMed
-
- Absah I, Rishi A, Talley NJ, Katzka D, Halland M. Rumination syndrome: pathophysiology, diagnosis, and treatment. Neurogastroenterol Motil. 2017;29(4). - PubMed
-
- Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99–114. e3. - PubMed
-
- Thompson W, Irvine E, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Digestive diseases and sciences. 2002;47(1):225–35. - PubMed
-
- Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. US householder survey of functional gastrointestinal disorders. Digestive diseases and sciences. 1993;38(9):1569–80. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical